Clinical utility of sarcopenia dynamics assessed by psoas muscle volume in patients with colorectal cancer

被引:0
|
作者
Kumamoto, Tomotaka [1 ,2 ]
Takamizawa, Yasuyuki [1 ]
Miyake, Mototaka [3 ]
Inoue, Manabu [1 ]
Moritani, Konosuke [1 ]
Tsukamoto, Shunsuke [1 ]
Eto, Ken [2 ]
Kanemitsu, Yukihide [1 ]
机构
[1] Natl Canc Ctr, Dept Colorectal Surg, 5-1-1 Tsukiji,Chuo Ku, Tokyo 1040045, Japan
[2] Jikei Univ, Sch Med, Dept Surg, Chuo Ku, Tokyo, Japan
[3] Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, Tokyo, Japan
关键词
colorectal cancer; psoas muscle volume; sarcopenia dynamics; SKELETAL-MUSCLE; MORTALITY; RESECTION; OUTCOMES; INDEX; MASS; COMPLICATIONS; PREVALENCE; IMPACT;
D O I
10.1002/wjs.12302
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundSarcopenia affects the postoperative prognosis of patients with colorectal cancer (CRC). Recently, it has become possible to measure psoas volume from computed tomography images, and an index called psoas volume index (PVI) has been reported. However, it is unclear whether the dynamics of PVI before and after surgery is associated with clinical outcomes after CRC surgery. This study aimed to evaluate the association between pre- and postoperative PVI dynamics and clinical outcomes after CRC surgery.MethodsThis study analyzed 1115 patients diagnosed with primary CRC and operated on for treatment between January 2014 and December 2017. Sarcopenia was defined as PVI below the lowest tertile in the preoperative assessment for each sex. The overall population was divided into four groups according to the dynamics of sarcopenia from preoperative to postoperative: group 1 (pre-to postoperative sarcopenia), group 2 (preoperative nonsarcopenia to postoperative sarcopenia), group 3 (pre-to postoperative nonsarcopenia), and group 4 (pre-to postoperative nonsarcopenia).ResultsBased on pre- and postoperative sarcopenia dynamics, 343 patients (29.7%) were classified into group 1, 105 patients (9.1%) into group 2, 42 patients (3.6%) into group 3, and 665 patients (57.6%) into group 4. Comparison of overall survival (OS) by the Kaplan-Meier method showed that Group 2 tended to have the worst prognosis (p = 0.007). Multivariate analysis showed an increased OS risk in Group 2 in sarcopenia dynamics (Hazard ratio: 2.103, 95% CI: 1.202-3.681, p = 0.009).ConclusionsSarcopenia dynamics using PVI is an independent prognostic predictor of OS in patients with CRC.
引用
收藏
页码:2098 / 2108
页数:11
相关论文
共 50 条
  • [21] The relationship between computed tomography derived skeletal muscle index, psoas muscle index and clinical outcomes in patients with operable colorectal cancer
    Abbass, Tanvir
    Ho, Yeung Timothy Tsz
    Horgan, Paul G.
    Dolan, Ross D.
    McMillan, Donald C.
    CLINICAL NUTRITION ESPEN, 2020, 39 : 104 - 113
  • [22] Low muscle mass assessed by psoas muscle area is associated with clinical adverse events in elderly patients with heart failure
    Funamizu, Takehiro
    Nagatomo, Yuji
    Saji, Mike
    Iguchi, Nobuo
    Daida, Hiroyuki
    Yoshikawa, Tsutomu
    PLOS ONE, 2021, 16 (02):
  • [23] PSOAS MUSCLE VOLUME IS PREDICTIVE FACTOR FOR POOR SURVIVAL IN ELDERLY OVARIAN CANCER PATIENTS
    Tomita, Y.
    Takenaka, M.
    Hirose, S.
    Komazaki, H.
    Ezawa, M.
    Kitai, S.
    Saito, M.
    Tanabe, H.
    Yamada, K.
    Takano, H.
    Okamoto, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A148 - A149
  • [24] Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer
    Rutten, Iris J. G.
    Ubachs, Jorne
    Kruitwagen, Roy F. P. M.
    Beets-Tan, Regina G. H.
    Damink, Steven W. M. Olde
    Van Gorp, Toon
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2017, 8 (04) : 630 - 638
  • [25] PSOAS MUSCLE AREA IS NOT REPRESENTATIVE OF TOTAL SKELETAL MUSCLE AREA IN THE ASSESSMENT OF SARCOPENIA IN OVARIAN CANCER
    Ubachs, J.
    Rutten, I.
    Kruitwagen, R.
    van Gorp, T.
    Beets-Tan, R.
    Damink, S. Olde
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1701 - 1701
  • [26] Psoas Muscle Area as a Novel Index of Sarcopenia Predicts Early Clinical Adverse Events in Patients With Heart Failure
    Funamizu, Takehiro
    Nagatomo, Yuji
    Saji, Mike
    Yoshikawa, Tsutomu
    CIRCULATION, 2018, 138
  • [27] Evaluation of Sarcopenia by Psoas Muscle Measurements in Osteoporotic Patients with Vertebral Compression Fracture
    Atik, Irfan
    Gul, Enes
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (06): : 713 - 716
  • [28] Clinical utility of a serum glycome analysis in patients with colorectal cancer
    Takei, Daisuke
    Harada, Keita
    Nouso, Kazuhiro
    Miyahara, Koji
    Dohi, Chihiro
    Matsushita, Hiroshi
    Kinugasa, Hideaki
    Hiraoka, Sakiko
    Nishimura, Shin-Ichiro
    Okada, Hiroyuki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (04) : 727 - 733
  • [29] Clinical utility of analysing ctDNA in patients with metastatic colorectal cancer
    Tabernero, Josep
    ANNALS OF ONCOLOGY, 2021, 32 : S230 - S230
  • [30] Psoas Muscle Volume Is a Predictive Marker of Fatigue and Anorexia in Prostate Cancer Patients Treated with Enzalutamide
    Kashiwagi, Eiji
    Shiota, Masaki
    Lee, Ken
    Monji, Keisuke
    Naganuma, Hidekazu
    Matsumoto, Takashi
    Takeuchi, Ario
    Inokuchi, Junichi
    Eto, Masatoshi
    JMA JOURNAL, 2022, 5 (04): : 491 - 497